Form 4: NeueHealth Director Forest Baskett Acquires Warrants
SEC Form 4
Director Forest Baskett reports the acquisition of warrants for NeueHealth, Inc. through a transaction dated April 8, 2024.
Summary
- Forest Baskett, a director of NeueHealth, Inc., filed a Form 4 disclosing the acquisition of warrants.
- The transaction occurred on April 8, 2024.
- The warrants are exercisable for common stock at a price of $0.01.
- A total of 371,187 warrants were acquired indirectly through NEA Partners 15, NEA Partners 16, and NEA Partners 17.
- The warrants are issued pursuant to a Warrantholders Agreement and a Credit Agreement.
- The warrants will be exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Future Outlook
The warrants will be exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in the company's securities. This filing indicates changes in beneficial ownership and helps investors understand the actions of those with inside knowledge of the company.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have similar insider transaction filings, reflecting the common practice of stock and warrant ownership among executives and directors.
Stakeholder Impact
- The acquisition of warrants by a director could be perceived positively by shareholders as it aligns the director's interests with the company's success.
- The issuance of warrants may dilute existing shareholders' equity if the warrants are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| February 29, 2024 | Date of Power of Attorney signing. |
| August 4, 2023 | Date of the Credit Agreement. |
| October 2, 2023 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| April 8, 2024 | Date of transaction and Warrantholders Agreement; Date of Incremental Amendment No. 2 to the Credit Agreement. |
| April 10, 2024 | Date of signature of the report by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.